Revenue | ₹0.23Cr |
Net Profits | ₹0.31Cr |
Net Profit Margins | -134.78% |
Biogen Pharmachem Industries Ltd’s revenue jumped 155.56% since last year same period to ₹0.23Cr in the Q3 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 135.38% jump in its revenue since last 3-months.
Biogen Pharmachem Industries Ltd’s net profit fell -616.67% since last year same period to ₹0.31Cr in the Q3 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 69% jump in its net profits since last 3-months.
Biogen Pharmachem Industries Ltd’s net profit margin fell -302.17% since last year same period to -134.78% in the Q3 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -187.61% fall in its net profit margins since last 3-months.
The revenue for Biogen Pharmachem Industries Ltd in the Q3 results 2024 was ₹0.23Cr.
The net profit for Biogen Pharmachem Industries Ltd in the Q3 results 2024 was ₹0.31Cr.
The net profit margin for Biogen Pharmachem Industries Ltd in the Q3 results 2024 was -134.78%.
The revenue for Biogen Pharmachem Industries Ltd in the Q3 results 2023 was ₹0.09Cr.
The net profit for Biogen Pharmachem Industries Ltd in the Q3 results 2023 was ₹0.06Cr.
The net profit margin for Biogen Pharmachem Industries Ltd in the Q3 results 2023 was 66.67%.